Baxter International | BAX

Stock Price
24.42
Daily Change
0.84 3.56%
Monthly
8.53%
Yearly
-37.34%
Q3 Forecast
24.42

Peers Price Chg Day Year Date
Terumo 2,645.50 20.00 0.76% -0.02% Sep/05
Abbott 132.94 0.13 0.10% 16.68% Sep/05
AtriCure 35.38 -0.28 -0.79% 34.83% Sep/05
Avanos Medical 12.72 0.06 0.47% -46.37% Sep/05
Baxter International 24.42 0.84 3.56% -37.34% Sep/05
Becton, Dickinson and Co. 192.39 1.13 0.59% -17.28% Sep/05
Boston Scientific 107.22 -0.07 -0.07% 31.36% Sep/05
Cooper Companies 68.08 0.08 0.12% -36.14% Sep/05
Quest Diagnostics 183.49 3.38 1.88% 20.12% Sep/05
Dexcom 80.54 -0.22 -0.27% 17.15% Sep/05
Edwards Lifesciences 80.94 -0.02 -0.02% 21.19% Sep/05
Fresenius 46.82 -0.36 -0.76% 40.94% Sep/05
Globus Medical 60.30 0.01 0.02% -14.83% Sep/05
Halozyme Therapeutics 74.93 1.53 2.08% 26.55% Sep/05
Integra LifeSciences 15.99 0.34 2.17% -13.57% Sep/05
ICU Medical 131.24 5.61 4.47% -19.15% Sep/05
Intuitive Surgical 466.95 12.43 2.73% -1.04% Sep/05
J&J 178.38 -0.38 -0.21% 8.48% Sep/05
Laboratory Of America 278.67 3.44 1.25% 24.30% Sep/05
Masimo 147.19 4.18 2.92% 31.97% Sep/05
Medtronic 92.93 0.13 0.14% 3.32% Sep/05
Merit Medical Systems 92.95 0.80 0.87% -3.76% Sep/05
Insulet 348.43 1.96 0.57% 62.25% Sep/05
Smith & Nephew 1,416.00 6.00 0.43% 18.15% Sep/05
Stryker 392.31 -2.03 -0.51% 9.17% Sep/05
Teleflex 130.70 1.61 1.25% -46.61% Sep/05
Tandem Diabetes Care 12.58 0.19 1.53% -70.33% Sep/05
Zimmer Biomet Holdings 105.69 0.93 0.89% 0.72% Sep/05

Indexes Price Day Year Date
US500 6481 -20.59 -0.32% 19.84% Sep/05

Baxter International traded at $24.42 this Friday September 5th, increasing $0.84 or 3.56 percent since the previous trading session. Looking back, over the last four weeks, Baxter International gained 8.53 percent. Over the last 12 months, its price fell by 37.34 percent. Looking ahead, we forecast Baxter International to be priced at 24.42 by the end of this quarter and at 23.63 in one year, according to Trading Economics global macro models projections and analysts expectations.

Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.